Lincoff, A M, Nicholls, S J, Riesmeyer, J S, Barter, P J, Brewer, H B, Fox, K A A, Gibson, C M, Granger, C, Menon, V, Montalescot, G, Rader, D, Tall, A R, McErlean, E, Wolski, K, Ruotolo, G, Vangerow, B, Weerakkody, G, Goodman, S G, Conde, D, McGuire, D K, Nicolau, J C, Leiva-Pons, J L, Pesant, Y, Li, W, Kandath, D, Kouz, S, Tahirkheli, N & Mason, D & Nissen, S E 2017, ' Evacetrapib and Cardiovascular Outcomes in High-Risk Vascular Disease ', New England Journal of Medicine, vol. 376, no. 20, pp. 1933-1942 . https://doi.org/10.1056/NEJMoa1609581
Thrombosis Journal. 2019;17:7 UCrea Repositorio Abierto de la Universidad de Cantabria Universidad de Cantabria (UC) Thrombosis Journal, Vol 17, Iss 1, Pp 1-11 (2019) Thrombosis Journal
The Lancet The Lancet, Elsevier, 2019, 394 (10204), pp.1169-1180. ⟨10.1016/S0140-6736(19)31887-2⟩ The Lancet (London), 394, 1169-1180 Bhatt, D L, Steg, P G, Mehta, S R, Leiter, L A, Simon, T, Fox, K, Held, C, Andersson, M, Himmelmann, A, Ridderstråle, W, Chen, J, Song, Y, Diaz, R, Goto, S, James, S K, Ray, K K, Parkhomenko, A N, Kosiborod, M N, McGuire, D K, Harrington, R A & THEMIS Steering Committee and Investigators 2019, ' Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI) : a phase 3, placebo-controlled, randomised trial ', Lancet, vol. 394, no. 10204, pp. 1169-1180 . https://doi.org/10.1016/S0140-6736(19)31887-2 The Lancet (London), 394, 10204, pp. 1169-1180
NEW ENGLAND JOURNAL OF MEDICINE r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe instname